...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
Can the O-Shot improve natural lubrication?

Can the O-Shot improve natural lubrication?

Can the O-Shot improve natural lubrication?

Can the O-Shot improve natural lubrication?

Can the O-Shot improve natural lubrication? | WHC Clinical FAQ

Can the O-Shot improve natural lubrication? | WHC Clinical FAQ

Can the O-Shot improve vaginal tissue quality?

Can the O-Shot improve vaginal tissue quality?


Assessment first
Evidence-aware
Safety focused

Women’s Health Clinic FAQ

Can the O-Shot improve natural lubrication?

Natural lubrication is influenced by hormones, tissue comfort, arousal, medication, irritation and pain. The useful question is not only whether PRP may help, but whether it fits the reason lubrication has changed.

Direct answer

The O-Shot may improve natural lubrication for selected patients when reduced lubrication appears linked to local tissue quality, blood flow, sensitivity or low-oestrogen tissue change. It uses platelet-rich plasma from your own blood, injected after assessment, with the aim of supporting tissue repair and lubrication response. It cannot promise a predictable lubrication result and should not replace assessment for menopause symptoms, infection, vulval skin conditions, medication effects, pain or arousal-related concerns.

Clarify whether the issue is dryness at rest, reduced wetness during arousal, friction, soreness, burning, pain or loss of sensitivity, because each pattern can point to a different cause.

Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation for natural lubrication and O-Shot suitability
Consultation-led care

At a glance

These are the key points to understand before considering PRP for natural lubrication.

At a glance

Clinical summary

What it is

Platelet-rich plasma prepared from a blood sample and injected after assessment.

May suit

Selected patients where natural lubrication appears linked to tissue quality or low-oestrogen change.

Evidence status

Evidence is developing; response and protocols vary.

First step

Clarify the symptom pattern before choosing treatment.

Important suitability note

New, severe, worsening or unexplained symptoms should be assessed before elective intimate treatment.

Symptoms
Menopause
PRP
Assessment
Aftercare




Detailed answer

How PRP may relate to lubrication

Natural lubrication is not a simple on-off function, so the O-Shot should be discussed as a possible tissue-support option rather than a universal lubrication treatment.

Clinical context

Lubrication can be affected by low oestrogen, vaginal atrophy, arousal response, pain, pelvic-floor tension, medication and vulval irritation. PRP may be relevant only after those drivers have been considered.

Tissue quality
Comfort
Low oestrogen
Alternatives

What the O-Shot is

A blood sample is processed to concentrate platelets. The platelet-rich plasma is then injected into selected intimate tissue after consent and numbing.

How it may work

Platelet signalling proteins are involved in repair pathways such as collagen support, blood-vessel formation, hydration and tissue resilience.

What it does not replace

PRP does not replace diagnosis, infection checks, vulval skin assessment, pelvic-floor review or menopause care when those are relevant.

Why symptoms matter

Clarify whether the issue is dryness at rest, reduced wetness during arousal, friction, soreness, burning, pain or loss of sensitivity, because each pattern can point to a different cause.

What this means in practice

Established options such as moisturisers, lubricants, local hormone discussion, vulval care or pelvic-floor support may be needed before or alongside PRP.

If PRP is suitable, the aim is usually gradual tissue support rather than an instant or certain response. Non-response should lead to reassessment.





Patient safety

Why proper assessment matters

Natural lubrication can have hormonal, inflammatory, medication-related, skin-related, pain-related or arousal-related drivers.

It identifies the cause

The right treatment depends on whether symptoms are linked to low oestrogen, irritation, infection, vulval skin change, medication, pain or arousal.

It protects safety

Bleeding, unusual discharge, fever, severe pain, new numbness or urinary change should be reviewed before elective intimate treatment.

It avoids over-treatment

Some patients need established conservative, hormonal, dermatological, pelvic-floor or psychosexual support rather than PRP first.

It sets expectations

PRP response is gradual and variable. It may support tissue quality, but it cannot promise one predictable outcome.

A symptom map is more useful than a treatment label

Clarify whether the issue is dryness at rest, reduced wetness during arousal, friction, soreness, burning, pain or loss of sensitivity, because each pattern can point to a different cause.

That distinction helps decide whether PRP is worth discussing, whether another pathway should come first, or whether combined care is more appropriate.





Considerations

What to consider before booking

Before choosing the O-Shot for natural lubrication, it is important to understand the cause, evidence limits, procedure, aftercare and alternatives.

Consultation priorities

Your clinician should review symptoms, menopause history, medication, vulval skin, pain, infections, urinary symptoms, previous treatments and goals before discussing PRP.

History
Examination
Consent
Follow-up

Before treatment

You may need review for infection, abnormal bleeding, vulval skin change, pelvic pain, medication effects or menopause-related tissue change before PRP is considered.

During the procedure

The appointment usually involves consent, cleansing, blood draw, centrifuge preparation, numbing and fine injections with pressure or brief stinging possible.

Aftercare

Aftercare commonly includes avoiding sex, baths and swimming for 24 to 48 hours while injection points settle, plus advice on symptoms to report.

Medication review

Some PRP protocols advise avoiding NSAIDs such as ibuprofen or aspirin around treatment because platelet activity is part of the intended response.

Practical expectations

Pricing and treatment plans should be confirmed on the /pricing/ page or with the clinic before booking.

A follow-up discussion is useful if symptoms do not improve, discomfort persists, or the pattern suggests a different underlying cause.





Common concerns and myths

Common misunderstandings

Clear information matters because intimate symptoms are often marketed as though one treatment can solve several different problems.

Myth: PRP promises lubrication

Reality: PRP may support tissue quality in selected patients, but lubrication depends on hormones, arousal, comfort, pain and local tissue health.

Myth: lubrication and desire are the same

Reality: desire, arousal, lubrication, pain and orgasm are connected but different. A good plan separates them before suggesting treatment.

Myth: no assessment is needed

Reality: intimate symptoms can overlap with infection, vulval skin disease, pelvic-floor pain and menopause-related change, so assessment matters.

Evidence and uncertainty

Research into vaginal PRP is growing, but preparation methods, injection protocols and outcome measures vary, so cautious language is important.

Alternatives and combined care

Moisturisers, lubricants, local hormone options, vulval care, pelvic-floor care and psychosexual support may be more appropriate first or may sit alongside PRP.





Safety checklist

Safety checklist

Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or urgent advice.

Has the cause been assessed?

Symptoms should be mapped by pattern, medical history, medication, menopause status and any pain, bleeding, discharge or urinary change.

Are symptoms stable?

New, severe, worsening or unexplained symptoms should be reviewed before an elective intimate procedure.

Are options clear?

Ask how PRP compares with conservative care, local hormone discussion, pelvic-floor support or other relevant options.

Is follow-up planned?

You should know what to expect, what aftercare to follow, when to seek help and when the response will be reviewed.

Reassuring signs

It is more reasonable to discuss PRP when symptoms have been assessed, red flags are absent, goals are realistic and alternatives have been explained.

Assessed
Realistic goals
Aftercare clear

Reasons to pause

Pause and seek medical review if symptoms include unexplained bleeding, unusual discharge, fever, severe pain, new numbness, vulval lesions or sudden urinary change.

Bleeding
Infection signs
New numbness




When to escalate

When to seek medical help

Some symptoms should be assessed promptly before any elective intimate treatment is considered. Use NHS 111 online

Severe or worsening pain

Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.

Bleeding or discharge

Unexplained bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed before treatment.

Infection signs

Fever, feeling unwell, spreading redness, pus, worsening swelling or urinary infection symptoms need prompt clinical advice.

New numbness or bladder change

Sudden genital numbness, numbness into the legs, new weakness or sudden bladder change should be assessed urgently.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Next step

Book a clinical consultation

A consultation can confirm whether PRP is worth discussing, whether another pathway should come first, and what realistic outcomes and aftercare would look like.

View Research Sources (12 Sources)
• Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review - PubMed
• Gynaecological conditions | Topic | NICE
• Menopause - Treatment - NHS
• Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A randomised Controlled Trial - PubMed
• Critical Sources in gynaecology, Volume 2: RCOG Scientific Impact Paper - Routledge
• Scientific Impact Papers | RCOG
• Stem Cell Therapies in Obstetrics and Gynaecology (Scientific Impact Paper No. 38) - RCOG
• Urology & Continence Care Today - Article: Genitourinary syndrome of menopause: new consensus statement from the British Menopause Society
• Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomised controlled study - PMC
• Stem Cell Therapies in Obstetrics and Gynaecology: The Female Urogenital - Tract and the Fetus as Sources and Targets for Molecular and Regenerative Medicine - RCOG
• Study Details | NCT05279560 | Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation | ClinicalTrials.gov
• Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 135 imported records. Additional reviewed material included peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. The O-Shot is an off-label, investigational PRP procedure for this context, and suitability must be confirmed after an individual consultation. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.

Loading directory...